<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629353</url>
  </required_header>
  <id_info>
    <org_study_id>THRIVE during LMS</org_study_id>
    <nct_id>NCT03629353</nct_id>
  </id_info>
  <brief_title>The Efficacy of Transnasal Humidified Rapid-insufflation Ventilatory Exchange During Laryngeal Microsurgery</brief_title>
  <official_title>The Efficacy of Transnasal Humidified Rapid-insufflation Ventilatory Exchange in Patients Undergoing Laryngeal Microsurgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) was revealed to&#xD;
      prolong apneic time with a slow increase in carbon dioxide; thus, has been used for&#xD;
      preoxygenation in patients with difficult airways or requiring rapid sequence induction in&#xD;
      general anesthesia.&#xD;
&#xD;
      However, in patients undergoing hypopharyngeal and laryngo-tracheal surgery, THRIVE during&#xD;
      operation can be advantageous by allowing tubeless surgical field with sufficient&#xD;
      oxygenation.&#xD;
&#xD;
      Therefore, the investigators conducted this study to evaluate the efficacy of THRIVE on&#xD;
      prolonged apneic time with enhanced surgical conditions in patients with laryngeal&#xD;
      microsurgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing laryngeal microsurgery will be randomized into either intubation group or&#xD;
      THRIVE group.&#xD;
&#xD;
      On arriving operating room, the patients will be preoxygenated by facemask or high flow nasal&#xD;
      cannula with 100% oxygen for 3 minutes according to the allocated group. After inducing&#xD;
      general anesthesia, patients in intubation group will be oxygenated by endotracheal tube,&#xD;
      while patients in THRIVE group will be oxygenated by high flow nasal cannula with flow rate&#xD;
      of 70L/min. During the surgery, the endotracheal tube can be removed and reintubated in&#xD;
      intubation group patients to provide surgical field by a surgeon, respectively.&#xD;
&#xD;
      The monitored pulse oximetry, oxygen reserve index, and transcutaneous partial pressure of&#xD;
      carbon dioxide will be recorded during surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 17, 2018</start_date>
  <completion_date type="Actual">February 24, 2020</completion_date>
  <primary_completion_date type="Actual">February 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lowest oxygen saturation</measure>
    <time_frame>from the time of starting laryngeal microsurgery till the end of the surgery</time_frame>
    <description>lowest oxygen saturation monitored by pulse oximetry during laryngeal microsurgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lowest oxygen reserve index</measure>
    <time_frame>from the time of starting laryngeal microsurgery till the end of the surgery</time_frame>
    <description>lowest oxygen reserve index monitored during laryngeal microsurgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>highest transcutaneous partial pressure of carbon dioxide</measure>
    <time_frame>from the time of starting laryngeal microsurgery till the end of the surgery</time_frame>
    <description>highest transcutaneous partial pressure of carbon dioxide monitored during laryngeal microsurgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Apneic Oxygenation</condition>
  <arm_group>
    <arm_group_label>intubation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The enrolled patients will be oxygenated by endotracheal tube during operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>THRIVE group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The enrolled patients will be oxygenated by intubationless high flow nasal cannula during operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endotracheal intubation</intervention_name>
    <description>After preoxygenation with FiO2 1.0 and flow rate of 8 L/min for 3 minutes, the enrolled patients will be intubated with endotracheal tube and maintained oxygenation during surgery.</description>
    <arm_group_label>intubation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high flow nasal cannula</intervention_name>
    <description>After preoxygenation with 100% oxygen through high flow nasal cannula for 3 minutes, the enrolled patients will be maintained intubationless oxygenation with flow rate of 70 L/min during surgery.</description>
    <arm_group_label>THRIVE group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing laryngeal microsurgery&#xD;
&#xD;
          -  ASA class I-III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients scheduled for laryngeal microsurgery using CO2 laser&#xD;
&#xD;
          -  patients with increased intracranial pressure&#xD;
&#xD;
          -  patients with skull base defect&#xD;
&#xD;
          -  patients with chronic obstructive pulmonary disease&#xD;
&#xD;
          -  patients with pulmonary hypertension&#xD;
&#xD;
          -  patients requiring rapid sequence induction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Youn Joung Cho, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>November 19, 2020</last_update_submitted>
  <last_update_submitted_qc>November 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Youn Joung Cho, MD</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>airway management</keyword>
  <keyword>high flow nasal cannula</keyword>
  <keyword>laryngeal microsurgery</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

